Characterization of the L-arginine–NO–cGMP pathway in spontaneously hypertensive rat platelets: the effects of pregnancy

[1]  L. Myatt.  Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta. , 2010, Placenta.

[2]  P. Kaufmann,et al.  Vasodilator factors in the systemic and local adaptations to pregnancy , 2009, Reproductive biology and endocrinology : RB&E.

[3]  J. Garthwaite,et al.  Mechanisms of Activity-dependent Plasticity in Cellular Nitric Oxide-cGMP Signaling* , 2009, The Journal of Biological Chemistry.

[4]  G. Jackson,et al.  Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity. , 2009, Cardiovascular research.

[5]  S. Cuzzocrea,et al.  Maternal adaptation in pregnant hypertensive rats: improvement of vascular and inflammatory variables and oxidative damage in the kidney. , 2009, American journal of hypertension.

[6]  K. Naseem,et al.  Globular adiponectin increases cGMP formation in blood platelets independently of nitric oxide , 2008, Journal of thrombosis and haemostasis : JTH.

[7]  J. Zweier,et al.  Activation of Hsp90-eNOS and increased NO generation attenuate respiration of hypoxia-treated endothelial cells. , 2008, American journal of physiology. Cell physiology.

[8]  D. Schwartz,et al.  A profound decrease in maternal arginine uptake provokes endothelial nitration in the pregnant rat. , 2008, American journal of physiology. Heart and circulatory physiology.

[9]  G. Mann,et al.  Chronic exercise reduces platelet activation in hypertension: upregulation of the l‐arginine‐nitric oxide pathway , 2008, Scandinavian journal of medicine & science in sports.

[10]  E. Melloni,et al.  Proteolytic degradation of nitric oxide synthase isoforms by calpain is modulated by the expression levels of HSP90 , 2007, The FEBS journal.

[11]  G. Lip,et al.  Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy , 2007, Expert review of cardiovascular therapy.

[12]  G. Mann,et al.  Platelet nitric oxide synthesis in uremia and malnutrition: a role for L-arginine supplementation in vascular protection? , 2007, Cardiovascular research.

[13]  C. Page,et al.  Increased platelet aggregation in vivo in the Zucker Diabetic Fatty rat: differences from the streptozotocin diabetic rat , 2007, British journal of pharmacology.

[14]  E. Ha,et al.  Reduced L-arginine level and decreased placental eNOS activity in preeclampsia. , 2006, Placenta.

[15]  J. Joles,et al.  blood pressure in adult SHR by shifting the perinatal balance of NO and reactive oxygen species towards NO : the inverted Barker phenomenon , 2004 .

[16]  P. Jurasz,et al.  Platelet–leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases , 2004, British journal of pharmacology.

[17]  R. Soares de Moura,et al.  CAPTOPRIL REVERSES THE REDUCED VASODILATOR RESPONSE TO BRADYKININ IN HYPERTENSIVE PREGNANT RATS , 2004, Clinical and experimental pharmacology & physiology.

[18]  G. Mann,et al.  Diminished L-arginine bioavailability in hypertension. , 2004, Clinical science.

[19]  J. Ellory,et al.  Inhibition of l‐arginine transport in platelets by asymmetric dimethylarginine and NG‐monomethyl‐l‐arginine: Effects of arterial hypertension , 2004, Clinical and experimental pharmacology & physiology.

[20]  D. Merrill,et al.  Enhanced expression of Ang-(1-7) during pregnancy. , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[21]  M. C. Rueda,et al.  Intrauterine Growth Restriction in Spontaneously Hypertensive Rats , 2004 .

[22]  P. Baker,et al.  An overview of endothelium-derived hyperpolarising factor (EDHF) in normal and compromised pregnancies. , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[23]  F. Hofmann,et al.  Direct activation of PDE5 by cGMP , 2003, The Journal of cell biology.

[24]  E. Coelho,et al.  Pregnancy-associated increase in rat systemic arteries endothelial nitric oxide production diminishes vasoconstrictor but does not enhance vasodilator responses. , 2002, Life sciences.

[25]  N. Eissa,et al.  Inducible Nitric-oxide Synthase Is Regulated by the Proteasome Degradation Pathway* , 2001, The Journal of Biological Chemistry.

[26]  R. Fischmeister,et al.  Cyclic GMP regulation of the L‐type Ca2+ channel current in human atrial myocytes , 2001, The Journal of physiology.

[27]  C. Stefanadis,et al.  Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases. , 2001, Atherosclerosis.

[28]  U. Walter,et al.  KT5823 Inhibits cGMP-dependent Protein Kinase Activity in Vitro but Not in Intact Human Platelets and Rat Mesangial Cells* , 2000, The Journal of Biological Chemistry.

[29]  A. Ferro,et al.  beta(2)-adrenoceptors activate nitric oxide synthase in human platelets. , 2000, Circulation research.

[30]  A. Bender,et al.  Ubiquitination of Neuronal Nitric-oxide Synthase in Vitro and in Vivo * , 2000, The Journal of Biological Chemistry.

[31]  D. Levy,et al.  Association of blood pressure with fibrinolytic potential in the Framingham offspring population. , 2000, Circulation.

[32]  R. Haslam,et al.  Cyclic Nucleotides and Phosphodiesterases in Platelets , 1999, Thrombosis and Haemostasis.

[33]  J. Bonnar,et al.  Nitric oxide in the uteroplacental, fetoplacental, and peripheral circulations in preeclampsia. , 1999, Obstetrics and gynecology.

[34]  C. Boyd,et al.  Transporters for cationic amino acids in animal cells: discovery, structure, and function. , 1998, Physiological reviews.

[35]  H. Morris,et al.  Hypothalamic hypertensive factor: an inhibitor of nitric oxide synthase activity. , 1997, Hypertension.

[36]  B. Morris,et al.  Influence of family history on frequency of glucagon receptor Gly40Ser mutation in hypertensive subjects. , 1997, Hypertension.

[37]  E. Coelho,et al.  Nitric oxide blunts sympathetic response of pregnant normotensive and hypertensive rat arteries. , 1997, Hypertension.

[38]  J. Loscalzo,et al.  Nitric oxide released from activated platelets inhibits platelet recruitment. , 1997, The Journal of clinical investigation.

[39]  L. Poston,et al.  Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. , 1996, American journal of obstetrics and gynecology.

[40]  B. Sibai,et al.  Cardiology patient page. Chronic hypertension in pregnancy. , 2007, Circulation.

[41]  S. Moncada,et al.  The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.

[42]  T. Lüscher.  Platelet-vessel wall interaction: role of nitric oxide, prostaglandins and endothelins. , 1993, Bailliere's clinical haematology.

[43]  U. Walter,et al.  The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. , 1993, Biochimica et biophysica acta.

[44]  S Moncada,et al.  Regulation of Vascular Homeostasis by Nitric Oxide , 1993, Thrombosis and Haemostasis.

[45]  D. Heistad,et al.  Seminars in medicine of the Beth Israel Hospital, Boston. Platelet-endothelium interactions. , 1993 .

[46]  C. Boyd,et al.  Identification of a new transport system (y+L) in human erythrocytes that recognizes lysine and leucine with high affinity. , 1992, The Journal of physiology.

[47]  S. Moncada,et al.  An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[48]  B. Brüne,et al.  Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. , 1987, Molecular pharmacology.

[49]  M. Paller.  Mechanism of decreased pressor responsiveness to ANG II, NE, and vasopressin in pregnant rats. , 1984, The American journal of physiology.

[50]  S. Moncada,et al.  Nitric oxide and the vascular endothelium. , 2006, Handbook of experimental pharmacology.

[51]  I. Johnson,et al.  Mechanisms of endothelium-dependent relaxation in myometrial resistance vessels and their alteration in preeclampsia. , 1999, Hypertension in pregnancy.

[52]  J. Aronson,et al.  Identification of system y+L as the high-affinity transporter for l-arginine in human platelets: up-regulation of l-arginine influx in uraemia , 1999, Pflügers Archiv.